EMULATE
Emulate is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.
EMULATE
Industry:
Biotechnology Health Care Life Science Medical
Founded:
2013-01-01
Address:
Boston, Massachusetts, United States
Country:
United States
Website Url:
http://www.emulatebio.com
Total Employee:
51+
Status:
Active
Contact:
+1 781 583 3515
Email Addresses:
[email protected]
Total Funding:
224.27 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF SSL By Default Google Font API Google Analytics LetsEncrypt Apple Mobile Web Clips Icon Google Tag Manager WordPress
Similar Organizations
Aulos Bioscience
Aulos Bioscience is dedicated to revolutionizing patient care in cancer with highly differentiated immuno-oncology therapeutics.
Novellus
Novellus is a biotechnology company working to develop engineered cellular medicines.
Ontera
Ontera develops a hand-held point of use diagnostic platform that examines DNA and RNA, and analytes from any life form.
Redcliffe Labs
Redcliffe is a one-stop diagnostic platform offering a wide selection of tests to choose from and delivering care closer to the customer.
Surface Oncology
Surface Oncology develops next-generation cancer immunotherapy treatments based on proprietary discoveries.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Investors List
Northpond Ventures
Northpond Ventures investment in Series E - Emulate
Perceptive Advisors
Perceptive Advisors investment in Series E - Emulate
Alumni Ventures
Alumni Ventures investment in Debt Financing - Emulate
Founders Fund
Founders Fund investment in Series D - Emulate
Northpond Ventures
Northpond Ventures investment in Series D - Emulate
Alumni Ventures
Alumni Ventures investment in Series D - Emulate
Ethos Family Office
Ethos Family Office investment in Venture Round - Emulate
Glass Wall Syndicate
Glass Wall Syndicate investment in Series C - Emulate
Starlight Ventures
Starlight Ventures investment in Series C - Emulate
ALS Investment Fund
ALS Investment Fund investment in Series C - Emulate
Official Site Inspections
http://www.emulatebio.com Semrush global rank: 1.55 M Semrush visits lastest month: 16.94 K
- Host name: 17.93.145.34.bc.googleusercontent.com
- IP address: 34.145.93.17
- Location: United States
- Latitude: 37.751
- Longitude: -97.822
- Timezone: America/Chicago
More informations about "Emulate"
About Us | Global Leader in Organ-on-a-Chip …
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21 st century technologies, we are able to overcome these limitations with …See details»
Emulate - Wikipedia
Emulate, Inc. (Emulate) is a biotechnology company that commercialized Organs-on-Chips technology—a human cell-based technology that recreates organ-level function to model organs in healthy and diseased states. The technology has applications in pharmaceutical research, product development, testing how different medicines, chemicals, and foods affect human health. E…See details»
Emulate - Crunchbase Company Profile & Funding
Organization. Emulate . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. Similar Companies. ... Contact Email [email protected]; Phone Number +1 781 583 3515; Emulate is a …See details»
Advance Your Career at Emulate
It’s our inclusive and diverse workforce that contributes to our success as an organization. Meet the Emulators. As a scientist at Emulate, I see the results from novel and challenging projects that are directly relatable and translatable to …See details»
Emulate, Inc. - LinkedIn
Emulate Inc. is a privately held company that creates advanced in vitro models for understanding how diseases, medicines, chemicals, and foods affect human health.See details»
Emulate, Inc. - MassBio
At Emulate, we understand that animal studies and reductionist models are limited because they are not based on integrated human biology. By leveraging 21st century technologies, we are …See details»
Emulate - Company info. interviews, news - BiopharmaTrend
Jan 25, 2024 17 Companies Building the Future of Drug Development on a Chip Jan. 25, 2024 In the early 2000s, the concept of organ-on-a-chip technology, also known as …See details»
Emulate Closes $82 Million Series E Financing to Scale Amid Rapid ...
Sep 7, 2021 For more information on Emulate, please visit emulatebio.com About Emulate Emulate is igniting a new era in human health with industry leading organ-on-a-chip technology.See details»
Global MPS Day 2023 - Emulate
The organization with the most votes will receive a $5,000 donation from Emulate. “The MPS industry has seen monumental growth since the first Organ-on-a-Chip and MPS technologies …See details»
Emulate Announces Organ-on-a-Chip Application and …
BOSTON, Jan. 8, 2021 /PRNewswire/ -- Emulate, Inc., a leading provider of advanced in vitro models, today announced an application roadmap for their market leading organ-on-a-chip technology that ...See details»
Emulate Unveils Chip-A1, Expanding Organ-on-a-Chip Technology ...
Jun 26, 2023 To learn more, visit emulatebio.com or follow us on LinkedIn and Twitter. Contacts Emulate, Inc. Michael Sullivan [email protected] +1 503-799-7520See details»
Emulate Closes $82 Million Series E Financing to Scale Amid Rapid ...
Sep 3, 2021 Company plans to expand research and development and scale commercial organization to support global customer base BOSTON, MA — September 7, 2021 — …See details»
Emulate Organ-Chips for Infectious Disease Research
Emulate Organ-Chips allow researchers to culture multiple human cell types in a dynamic, tissue-specific microenvironment, allowing for deeper insights into the complex and human-specific …See details»
Organ-Chips in Action: Examples from our User Community
A wide variety of human cells can be cultured using Emulate Organ-Chips, including primary cells, iPSCs, organoids, and immune cells. For modeling the liver, kidney, or intestine (duodenum or …See details»
Emulate Liver-Chip S1 Accepted into FDA's ISTAND Pilot Program.
Nov 6, 2024 Recently, we announced that the Emulate Liver-Chip S1 was accepted into the FDA’s ISTAND pilot program. To learn more, we sat down with Dr. Lorna Ewart, Chief …See details»
Emulate Brain-Chip
Neuroinflammation research has been hampered by the lack of a comprehensive human model that accurately emulates the brain and blood-brain barrier.See details»
Emulate human Organ-Chip Models
FEATURED RESOURCE. Publication: Performance Assessment and Economic Analysis of a Human Liver-Chip for Predictive Toxicology. Scientific and economic findings highlight the …See details»
ChipChat with Emulate: Answering Your Organ-Chip Questions Live
Curious about implementing Organ-on-a-Chip technology, but don’t know where to start? Or, have you started using Organ-Chips, but are wondering how to better optimize your results? During …See details»
Sign up for Chip-A1 Access - Emulate
In their online article titled ‘Epithelial-Stromal Interactions in Barrett’s Esophagus Modeled in Human Organ Chips,” researchers from the Wyss Institute in Boston using a prototype of Chip …See details»